Skip to Content

Notice

Oncologic Drugs Advisory Committee; Amendment of Notice

A Notice by the Food and Drug Administration on 12/09/2003

Document Details

Information about this document as published in the Federal Register.

Printed version:
PDF
Publication Date:
12/09/2003
Agencies:
Food and Drug Administration
Document Type:
Notice
Document Citation:
68 FR 68627
Page:
68627 (1 page)
Document Number:
03-30436
Document Details
Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Page views:
5
as of 05/28/2020 at 8:16 am EDT
Document Statistics
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Oncologic Drugs Advisory Committee. This meeting was announced in the Federal Register of November 18, 2003 (68 FR 65076-65077). The amendment is being made to reflect a change in the Location portion of the document. There are no other changes.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Johanna Clifford, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, or by express delivery to: 5630 Fishers Lane, rm. 1093, Rockville, MD 20852, 301-827-7001, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512542. Please call the Information Line for up-to-date information on this meeting.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In the Federal Register of November 18, 2003 (68 FR 65076-65077), FDA announced that a meeting of the Oncologic Drugs Advisory Committee would be held on December 16, 2003. On page 65077, in the first column, the Location portion of the meeting is amended to read as follows:

Location: CDER Advisory Committee conference rm. 1066, 5630 Fishers Lane, Rockville, MD.

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

Start Signature

Dated: December 3, 2003.

William K. Hubbard,

Associate Commissioner for Policy and Planning.

End Signature End Supplemental Information

[FR Doc. 03-30436 Filed 12-8-03; 8:45 am]

BILLING CODE 4160-01-S

Published Document